Redwood Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-82,072
Closed -$6.19M 133
2018
Q1
$6.19M Sell
82,072
-4,251
-5% -$338K 0.44% 91
2017
Q4
$6.18M Buy
+86,323
New +$6.56M 0.44% 94
2017
Q3
Sell
-10
Closed -$1K 154
2017
Q2
$1K Hold
10
﹤0.01% 170
2017
Q1
$1K Hold
10
﹤0.01% 179
2016
Q4
$1K Hold
10
﹤0.01% 168
2016
Q3
$1K Hold
10
﹤0.01% 170
2016
Q2
$1K Sell
10
-166,643
-100% -$14.8M ﹤0.01% 183
2016
Q1
$15.3M Buy
166,653
+4,580
+3% +$413K 1.52% 29
2015
Q4
$16.4M Buy
162,073
+21,017
+15% +$2.19M 1.76% 20
2015
Q3
$13.8M Buy
141,056
+140,778
+50,640% +$15.6M 1.84% 23
2015
Q2
$33K Sell
278
-42,057
-99% -$4.6M ﹤0.01% 159
2015
Q1
$4.15M Sell
42,335
-89,297
-68% -$9.07M 0.67% 48
2014
Q4
$12.4M Sell
131,632
-112,986
-46% -$11.7M 1.87% 17
2014
Q3
$26M Buy
244,618
+48,697
+25% +$4.77M 3.47% 2
2014
Q2
$16.2M Buy
+195,921
New +$15.3M 2.03% 18

Other funds holding GILD

Redwood Investments's GILD Position: Q2 2018 in Review

Redwood Investments sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 82,072 shares — an estimated $6.19M sold.

Redwood Investments first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $26M in Q3 2014. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Redwood Investments reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Redwood Investments sold 82,072 Gilead Sciences shares in Q2 2018, an estimated $6.19M.
  • Redwood Investments first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
  • Redwood Investments's Gilead Sciences position peaked at $26M in Q3 2014.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Redwood Investments's 13F filing for Q2 2018, filed 9 Aug 2018.